Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
FDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For Zymework
Via Benzinga
Exposures Product Safety
Tickers JAZZ ZYME
FDA Approves Cannabis Trial For Veterans With PTSD After Years Of Delays
Via Benzinga
Topics Cannabis
Exposures Cannabis Product Safety
FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
Via Benzinga
Exposures Product Safety
Tickers UCBJF UCBJY
National Law Firm Parker Waichman Discusses The Financial Impact Of A Tracheostomy Tube Defect Injury
Via Prodigy
Topics Death
Exposures Death Product Safety
CJ Biomaterials Completes Trials of New PHACT PHA Grade for Use by Straw Manufacturers Seeking Marine Degradability Certification
Via Newsfile
Exposures Product Safety
Marijuana Recalls in California Underscore Importance of Decontamination
Via Investor Brand Network
Topics Cannabis Product Recall
Exposures Cannabis Legal Product Safety
CCHR Urges FDA Overhaul to End Psychiatric Drug and Device Harms
Via PRLog
Exposures Product Safety
Bill Clinton Recalls Trump's Actions On January 6
Via Benzinga
Topics Government Product Recall
Exposures Legal Political Product Safety
New Single “Pike County Coal” Delivers Heartbreaking Tale of Labor, Loss, and Regret
Via AB Newswire
Topics Product Recall
Exposures Coal Legal Product Safety
Kaplan Fox &amp; Kilsheimer LLP Alerts Investors to a Securities Class Action Against Humacyte, Inc. (HUMA) - Deadline is January 17, 2025
Via TheNewswire.com
Exposures Product Safety
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) COO to Present at Winter 2024 Investor Summit
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Marijuana Recalls in California Underscore Importance of Decontamination
Via CannabisNewsWire
Topics Cannabis Product Recall
Exposures Cannabis Legal Product Safety
Tickers TSNDF TSX:TSND
CCHR Urges FDA to Finalize Its Proposed Ban of Electric Shocking Device Used on Autistic and Disabled Students
Via Press Release Distribution Service
Exposures Product Safety
ClearSight Highlights the Proven Safety and High Success of SMILE Eye Surgery in New Article
Via Press Advantage
Exposures Product Safety
Ispire And IKE Tech Advance FDA-Backed Age Verification Tech To Curb Youth Vaping
Via Benzinga
Exposures Product Safety
Tickers ISPR
Dave Ramsey Recalls The Day American Express Called His Wife, Asking Why Stay 'With A Man That Won't Pay His Bills.' Here's What He Did Next
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers AXP
BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Promising Preclinical Results for SPC-15 in Treating Severe Psychiatric Disorders
Via Investor Brand Network
Exposures Product Safety
Tickers SILO
BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Highlights Phase 3 Success for TNX-102 SL in Fibromyalgia Treatment
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Porsche Recalls Nearly 16K Taycan EVs In China Citing Fire Risk
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse
Via Newsfile
Exposures Product Safety
Tickers ELTP
CCHR Urges Drug and Device Approval Overhaul to End Psychiatric Harms
Via Press Release Distribution Service
Exposures Product Safety
Nikola Recalls 72 Of Its Trouble-Ridden BEV Trucks As Display Failure Raises Crash Risk
Via Benzinga
Topics Electric Vehicles Product Recall
Exposures Electric Vehicles Legal Product Safety
Tickers NKLA
European And US Vaccine Stocks Are Under Pressure - Here's WHy
Via Benzinga
Exposures Product Safety
Tickers AZN BNTX GSK INO
Robert Kennedy Poised To Lead Health And Human Services: Why FDA, NIH Officials Are Nervous
Via Benzinga
Topics Government
Exposures Political Product Safety
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
Via Benzinga
Exposures Product Safety
Tickers REGN SNY
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances Glioblastoma Treatment with Berubicin Amid Strong Financial Position
Via Investor Brand Network
Exposures Product Safety
Tickers CNSP
Lucid Recalls Over 1500 Units Of Air Sedan Over Loss Of Drive Power Concerns
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers LCID
We Are G.A.M.E. Celebrates Inspiring Alumni Success Stories: From The Air Force To Public Health Leadership With Haley Jones And Dakota Jones
Via Get News
Topics Product Recall
Exposures Legal Product Safety
FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain
Via Benzinga
Exposures Product Safety
Tickers PTCT
FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment
Via Benzinga
Exposures Product Safety
Tickers CMPS
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.